Arcus Biosciences Inc (RCUS)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,095,000 | 1,191,000 | 1,220,000 | 1,254,000 | 1,345,000 | 1,393,820 | 1,476,770 | 1,543,430 | 1,592,000 | 839,290 | 898,773 | 935,119 | 772,292 | 811,075 | 481,389 | 176,144 | 203,110 | 216,957 | 238,974 | 258,530 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,095,000K
= 0.00
The debt-to-assets ratio for Arcus Biosciences Inc has consistently been reported as 0.00 across all quarters for the years 2022 and 2023. This indicates that the company has not utilized any debt to finance its assets during this period. While a debt-to-assets ratio of 0.00 typically suggests that the company is not relying on debt for its operations, it is important to note that this ratio alone does not provide a complete picture of the company's financial health. Further analysis of the company's financial statements and business operations would be necessary to assess its overall financial stability and performance.
Peer comparison
Dec 31, 2023